Literature DB >> 3323144

Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase.

H Multhaupt1, P Fritz, K Schumacher.   

Abstract

Monoclonal antibodies against human liver arginase were raised in order to determine the exact distribution of arginase in human liver using a modified indirect unlabelled immunoperoxidase method. In normal human liver specific immunohistochemical staining was found in the cytoplasm of hepatocytes. Portal components (bile ducts and veins) and fibrous tissue were non-reactive, while erythrocytes were slightly positive. The specificity of the immunological reaction was confirmed by control tests. Spectrophotometry was used to quantitate the immunohistochemical reaction product, and the results indicated that arginase is homogeneously distributed in the liver lobule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323144     DOI: 10.1007/BF00496818

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  31 in total

1.  Influence of cations on the intracellular distribution of rat liver arginase.

Authors:  J D GORRY; B GOTTLIEB; O ROSENTHAL; H M VARS
Journal:  J Biol Chem       Date:  1956-11       Impact factor: 5.157

2.  Separation of arginase isoenzymes from human tissues by agar gel electrophoresis.

Authors:  O Borcić; B Straus
Journal:  J Clin Chem Clin Biochem       Date:  1976-11

3.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

4.  Purification and some properties of arginase from human lung.

Authors:  E Dahlig; Z Porembska; I Mochnacka
Journal:  Acta Biochim Pol       Date:  1975       Impact factor: 2.149

5.  Molecular forms of rat-liver arginase. Isolation and characterization.

Authors:  R Tarrab; J Rodríguez; C Huitrón; R Palacios; G Soberón
Journal:  Eur J Biochem       Date:  1974-11-15

6.  Inhibition of erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol.

Authors:  J G Streefkerk
Journal:  J Histochem Cytochem       Date:  1972-10       Impact factor: 2.479

7.  Immunodiffusion studies on human liver and erythrocyte arginases.

Authors:  J Cabello; V Prajoux; M Plaza
Journal:  Biochim Biophys Acta       Date:  1965-09-20

8.  Heterogeneous distribution of glutamine synthetase during rat liver development.

Authors:  J W Gaasbeek Janzen; R Gebhardt; G H ten Voorde; W H Lamers; R Charles; A F Moorman
Journal:  J Histochem Cytochem       Date:  1987-01       Impact factor: 2.479

9.  Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver.

Authors:  D Häussinger
Journal:  Eur J Biochem       Date:  1983-06-15

10.  The four subclasses of IgG can be isolated from mouse serum by using Protein A-Sepharose.

Authors:  I Seppälä; H Sarvas; F Péterfy; O Mäkelä
Journal:  Scand J Immunol       Date:  1981-10       Impact factor: 3.487

View more
  8 in total

1.  Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.

Authors:  Benjamin C Yan; Can Gong; Jie Song; Thomas Krausz; Maria Tretiakova; Elizabeth Hyjek; Hikmat Al-Ahmadie; Venancio Alves; Shu-Yuan Xiao; Robert A Anders; John A Hart
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

2.  Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.

Authors:  Gokce Askan; Vikram Deshpande; David S Klimstra; Volkan Adsay; Carlie Sigel; Jinru Shia; Olca Basturk
Journal:  Am J Clin Pathol       Date:  2016-07-17       Impact factor: 2.493

3.  Immunohistochemical study of arginase in cancer of the stomach.

Authors:  C W Wu; W W Chung; C W Chi; H L Kao; W Y Lui; F K P'eng; S R Wang
Journal:  Virchows Arch       Date:  1996-08       Impact factor: 4.064

4.  Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.

Authors:  Ifeyinwa Emmanuela Obiorah; Joeffrey Chahine; Kyungmin Ko; Byoung Uk Park; Jose deGuzman; Bhaskar Kallakury
Journal:  Gastroenterology Res       Date:  2019-04-07

5.  Well differentiated arginase-1 negative hepatocellular carcinoma.

Authors:  Ifeyinwa E Obiorah; Joeffrey Chahine; Byoung Uk Park; Kyungmin Ko; Jose deGuzman; Bhaskar Kallakury
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

6.  The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.

Authors:  Nehal A Radwan; Naglaa S Ahmed
Journal:  Diagn Pathol       Date:  2012-10-30       Impact factor: 2.644

7.  Aberrant expression and distribution of enzymes of the urea cycle and other ammonia metabolizing pathways in dogs with congenital portosystemic shunts.

Authors:  Giora van Straten; Frank G van Steenbeek; Guy C M Grinwis; Robert P Favier; Anne Kummeling; Ingrid H van Gils; Hille Fieten; Marian J A Groot Koerkamp; Frank C P Holstege; Jan Rothuizen; Bart Spee
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

8.  Hepatocyte paraffin 1 and arginase-1 are effective panel of markers in HBV-related HCC diagnosis in fine-needle aspiration specimens.

Authors:  Bita Moudi; Hamidreza Mahmoudzadeh-Sagheb; Zahra Heidari
Journal:  BMC Res Notes       Date:  2020-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.